These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18625752)

  • 1. Patients with pulmonary arterial hypertension in clinical trials: who are they?
    Hill NS; Preston IR; Roberts KE
    Proc Am Thorac Soc; 2008 Jul; 5(5):603-9. PubMed ID: 18625752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension].
    Tokgözoğlu L; Akdoğan A; Okutucu S; Kaya EB; Aytemir K; Ozkutlu H
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):378-83. PubMed ID: 20019450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL; Gomberg-Maitland M; Naeije R; Arneson CP; Lang IM
    J Heart Lung Transplant; 2011 Sep; 30(9):982-9. PubMed ID: 21531577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    Poms A; Kingman M
    Crit Care Nurse; 2011 Dec; 31(6):e1-10. PubMed ID: 22135338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.
    de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT
    Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
    Coghlan JG; Pope J; Denton CP
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S27-34. PubMed ID: 20375662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy in pulmonary arterial hypertension: a meta-analysis.
    Bai Y; Sun L; Hu S; Wei Y
    Cardiology; 2011; 120(3):157-65. PubMed ID: 22212696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst R
    Int J Clin Pract Suppl; 2010 Nov; (168):23-32. PubMed ID: 20939843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.
    Fox BD; Shimony A; Langleben D
    Am J Cardiol; 2011 Oct; 108(8):1177-82. PubMed ID: 21864815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
    Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S11-9. PubMed ID: 20375660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of intravenous L-carnitine in patients with right-sided heart failure induced by pulmonary arterial hypertension].
    Xu XQ; Jing ZC; Jiang X; Zhao QH; He J; Dai LZ; Wu WH; Li Y; Yao J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):152-5. PubMed ID: 20398563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H; Simonneau G; Galiè N; Higenbottam T; Naeije R; Rubin LJ; Nikkho S; Speich R; Hoeper MM; Behr J; Winkler J; Sitbon O; Popov W; Ghofrani HA; Manes A; Kiely DG; Ewert R; Meyer A; Corris PA; Delcroix M; Gomez-Sanchez M; Siedentop H; Seeger W;
    N Engl J Med; 2002 Aug; 347(5):322-9. PubMed ID: 12151469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional and alternative designs for pulmonary arterial hypertension trials.
    Gomberg-Maitland M
    Proc Am Thorac Soc; 2008 Jul; 5(5):610-6. PubMed ID: 18625753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.